POS0781 EFFICACY AND SAFETY OF ORAL DEUCRAVACITINIB IN PATIENTS WITH CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS: RESULTS FROM PAISLEY CLE, A GLOBAL, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL
J.F. Merola(The University of Texas Southwestern Medical Center), V.P. Werth(University of Pennsylvania), Brandon Becker(Bristol-Myers Squibb (United States)), C. Aranow(Feinstein Institute for Medical Research), Cristina Arriens(Oklahoma Medical Research Foundation), Bankole A. Johnson(Indiana University Bloomington), Nikolay Delev(Bristol-Myers Squibb (Sweden)), François Chasset(Sorbonne Université), Anna Luisa Kühn(University of Massachusetts Chan Medical School), David Fiorentino(Stanford University), A.B. Gottlieb(Icahn School of Medicine at Mount Sinai), Coburn Hobar(Bristol-Myers Squibb (United States)), Shimon Korish(Bristol-Myers Squibb (United States)), Renu Agrawal(Bristol-Myers Squibb (United States)), Beng H. Chong(The University of Texas Southwestern Medical Center), Jürgen J. Wenzel(Institute of Medical Microbiology and Hygiene), Jiyoon Choi(Bristol-Myers Squibb (United States)), Richard Meier(Bristol-Myers Squibb (United States)), Thomas Lehman(Hospital for Special Surgery), Ronald van Vollenhoven(Amsterdam University Medical Centers)
Cited by 5
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
|Nature Communications|2019|415
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414